The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of synchronous vs metachronous primary tumor resection on prognosis of BRAF-V600E mutant metastatic colorectal cancer (mCRC).
 
Arwa Ahmed
No Relationships to Disclose
 
William Philips
No Relationships to Disclose
 
Horia Marginean
No Relationships to Disclose
 
Timothy Asmis
Consulting or Advisory Role - Pfizer
 
Michael Vickers
No Relationships to Disclose
 
Bryan Lo
No Relationships to Disclose
 
Rachel Goodwin
Honoraria - Advanced Accelerator Applications; Eisai; Incyte; Incyte; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Bayer; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical; Viatris
Speakers' Bureau - Amgen; Bayer; Bayer; Eisai; Ipsen; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer